Product NDC: | 51525-7815 |
Proprietary Name: | Azelastine Hydrochloride |
Non Proprietary Name: | AZELASTINE HYDROCHLORIDE |
Active Ingredient(s): | .5 mg/mL & nbsp; AZELASTINE HYDROCHLORIDE |
Administration Route(s): | INTRAOCULAR |
Dosage Form(s): | SOLUTION/ DROPS |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51525-7815 |
Labeler Name: | Wallace Pharmaceuticals Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021127 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20101001 |
Package NDC: | 51525-7815-6 |
Package Description: | 1 BOTTLE, PLASTIC in 1 BOX (51525-7815-6) > 6 mL in 1 BOTTLE, PLASTIC |
NDC Code | 51525-7815-6 |
Proprietary Name | Azelastine Hydrochloride |
Package Description | 1 BOTTLE, PLASTIC in 1 BOX (51525-7815-6) > 6 mL in 1 BOTTLE, PLASTIC |
Product NDC | 51525-7815 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | AZELASTINE HYDROCHLORIDE |
Dosage Form Name | SOLUTION/ DROPS |
Route Name | INTRAOCULAR |
Start Marketing Date | 20101001 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Wallace Pharmaceuticals Inc. |
Substance Name | AZELASTINE HYDROCHLORIDE |
Strength Number | .5 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Inhibitor [EPC] |